Ready 8-Ks
18
Latest filing
May 5, 2026, 7:59 PM ET
Top materiality
0.90
Event mix
earnings ×10 · leadership ×4 · other ×3
Sentiment
5 pos · 0 neg · 13 neu
Latest earnings
reported 2026-Q1
-
Corteva Delivers Strong Q1 2026: EPS $1.07 GAAP, $1.50 Operating; Reaffirms FY Outlook
Net sales $4.905B (+11% YoY); organic sales +7%. GAAP net income $725M ($1.07 EPS).
-
Corteva names Luke Kissam CEO of New Corteva; reveals SpinCo leadership for planned separation
Luke Kissam, former Albemarle CEO, to lead New Corteva (crop protection) at Q4 2026 spin-off; joins June 1 as crop protection BU CEO.
-
Corteva FY2025 sales $17.4B (+3%), EBITDA $3.85B; guides 2026 EBITDA $4.0-4.2B; settles Bayer
Full-year GAAP EPS from cont ops $1.75, up 43% YoY; Operating EPS $3.34, up 30%.
-
Corteva raises FY2025 guidance; Q3 op EBITDA $49M; plans spin-off in H2 2026
Q3 net sales $2.62B, +13% YoY; GAAP loss $308M (loss $0.46) vs loss $519M prior year.
-
Corteva to split into two public companies via tax-free spin-off by H2 2026
Board unanimously approved plan to separate into two independent public companies via tax-free spin-off expected in H2 2026.
-
Corteva Q2 GAAP EPS $2.02, op EPS $2.20; raises FY2025 guidance
Q2 GAAP EPS $2.02 (up 34% YoY); operating EPS $2.20 (up 20%).
-
Corteva Q1 2025: EPS $0.97 GAAP, $1.13 operating; reaffirms FY guidance
GAAP EPS $0.97 from cont. ops (+83% YoY); operating EPS $1.13 (+27% YoY).
-
Corteva: Q4 Op EPS $0.32 vs -$0.08 GAAP; Seed & Crop Protection volumes up; FY2025 guidance $2.70-$2.95 Op EPS
GAAP diluted EPS from continuing ops -$0.08 in Q4 vs -$0.33 a year ago; Operating EPS $0.32, up 113% YoY.
-
Corteva reports Q3 loss, updates FY guidance, announces restructuring cost increase
Q3 2024 net sales $2.33B (-10% YoY); GAAP loss from cont. ops $519M; GAAP EPS -$0.76.
-
Corteva names Judd O'Connor EVP Seed Business Unit as Tim Glenn retires Dec 1, 2024
Tim Glenn will retire effective December 1, 2024, and serve as strategic advisor through Q1 2025.
-
Corteva Q2 GAAP EPS $1.51, up 23% YoY; cuts FY guidance; names new CFO
Seed EBITDA +16% to $1.70B on 5% price lift; Crop Protection EBITDA -20% to $255M on pricing pressure.
-
Corteva Q1 net sales down 8% to $4.49B, EPS $0.53; reaffirms FY guidance
GAAP EPS from continuing ops $0.53 vs $0.84 prior year; operating EPS (non-GAAP) $0.89 vs $1.16.
-
Corteva reports FY2023 operating EBITDA up 5% to $3.38B; provides 2024 guidance with mid-point growth
Q4 net sales $3.71B (-3% YoY); GAAP loss from cont. ops $231M (EPS -$0.33).